Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
236.7 USD | +1.14% | +10.41% | -8.52% |
01:12pm | Wedbush Adjusts Price Target on Biogen to $215 From $219 | MT |
12:25pm | Novartis, Roche, Biogen, Samsung Bioepis in Italy Eye-Medicine Probe | DJ |
Official Publications
SEC Filing 10Q-1 | CO | |
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
Annual ESG Report | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 10K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-2 | CO | |
1st-half-year results | CO |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Official Publications